Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
midodrine hydrochloride
Medication labelWhy this: Advisory · dailymed-prescription
ProAmatine ® is indicated for the treatment of symptomatic orthostatic hypotension (OH). Because ProAmatine ® can cause marked elevation of supine blood pressure (BP>200 mmHg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. The indication is based on ProAmatine ®'s effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. At present, however, clinical benefits of ProAmatine ®, principally improved ability to perform life activities, have not been established. Further clinical trials are underway to verify and describe the clinical benefits of ProAmatine ®. After initiation of treatment, ProAmatine ® should be continued only for patients who report significant symptomatic improvement.
- generic_name
- midodrine hydrochloride
- product_names
- midodrine hydrochloride
- ndc
- 54868-5442, 54092-004, 54868-5442-0, 54868-5442-1, 54868-5442-2
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en